Lafuente MP - Search Results

1

Brimonidine's neuroprotective effects against transient ischaemia-induced retinal ganglion cell death.

Vidal-Sanz M, Lafuente MP, Mayor-Torroglosa S, Aguilera ME, Miralles de Imperial J, Villegas-Pérez MP. Vidal-Sanz M, et al. Among authors: lafuente mp. Eur J Ophthalmol. 2001 Jul-Sep;11 Suppl 2:S36-40. doi: 10.1177/112067210101102S04. Eur J Ophthalmol. 2001. PMID: 11592529

2

Death and neuroprotection of retinal ganglion cells after different types of injury.

Vidal-Sanz M, Lafuente M, Sobrado-Calvo P, Selles-Navarro I, Rodriguez E, Mayor-Torroglosa S, Villegas-Perez MP. Vidal-Sanz M, et al. Among authors: lafuente m. Neurotox Res. 2000;2(2-3):215-27. doi: 10.1007/BF03033795. Neurotox Res. 2000. PMID: 16787842

3

Retinal ganglion cell death induced by retinal ischemia. neuroprotective effects of two alpha-2 agonists.

Vidal-Sanz M, Lafuente MP, Mayor S, de Imperial JM, Villegas-Pérez MP. Vidal-Sanz M, et al. Among authors: lafuente mp. Surv Ophthalmol. 2001 May;45 Suppl 3:S261-7; discussion S273-6. doi: 10.1016/s0039-6257(01)00205-3. Surv Ophthalmol. 2001. PMID: 11377446

4

Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death.

Lafuente MP, Villegas-Pérez MP, Sobrado-Calvo P, García-Avilés A, Miralles de Imperial J, Vidal-Sanz M. Lafuente MP, et al. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2074-84. Invest Ophthalmol Vis Sci. 2001. PMID: 11481275

5

Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult.

Lafuente MP, Villegas-Pérez MP, Sellés-Navarro I, Mayor-Torroglosa S, Miralles de Imperial J, Vidal-Sanz M. Lafuente MP, et al. Neuroscience. 2002;109(1):157-68. doi: 10.1016/s0306-4522(01)00458-4. Neuroscience. 2002. PMID: 11784707

6

Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study.

Lafuente MP, Villegas-Pérez MP, Mayor S, Aguilera ME, Miralles de Imperial J, Vidal-Sanz M. Lafuente MP, et al. Exp Eye Res. 2002 Feb;74(2):181-9. doi: 10.1006/exer.2001.1122. Exp Eye Res. 2002. PMID: 11950228

7

[No title available]

[No authors listed] [No authors listed] PMID: 28252730

8

Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine.

Avilés-Trigueros M, Mayor-Torroglosa S, García-Avilés A, Lafuente MP, Rodríguez ME, Miralles de Imperial J, Villegas-Pérez MP, Vidal-Sanz M. Avilés-Trigueros M, et al. Among authors: lafuente mp. Exp Neurol. 2003 Dec;184(2):767-77. doi: 10.1016/S0014-4886(03)00298-X. Exp Neurol. 2003. PMID: 14769369

9

The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment.

Lönngren U, Näpänkangas U, Lafuente M, Mayor S, Lindqvist N, Vidal-Sanz M, Hallböök F. Lönngren U, et al. Brain Res Bull. 2006 Dec 11;71(1-3):208-18. doi: 10.1016/j.brainresbull.2006.09.005. Epub 2006 Oct 2. Brain Res Bull. 2006. PMID: 17113948

10

Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review.

Lafuente M, Rodríguez González-Herrero ME, Romeo Villadóniga S, Domingo JC. Lafuente M, et al. Antioxidants (Basel). 2021 Mar 5;10(3):386. doi: 10.3390/antiox10030386. Antioxidants (Basel). 2021. PMID: 33807538 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters